This course has expired. View available courses.
English
New treatment option in cystic fibrosis: The role of CFTR modulation for patients with a G551D or other gating (class III) mutation – Certificate of Completion
DURATION
PROFESSION
Physician
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2018-02-16
Learning objectives
After completing this learning program, participants will be better able to:
- Appreciate the role of symptomatic treatments in managing patients with CF
- Describe the mechanism of action of CFTR modulators in clinical management of the disease
- Identify appropriate patients for currently-available CFTR modulator
- Communicate the role of CFTR modulators to patients with CF, to maximise adherence over the long term.